Rhizosphere processes play a critical role in phosphorus (P) acquisition by plants and microbes, especially under P-limited conditions. Here, we investigated the impacts of nutrient addition and plant species on plant growth, rhizosphere processes, and soil P dynamics. In a glasshouse experiment, blue lupin (), white clover ( L.), perennial ryegrass ( L.), and wheat ( L.) were grown in a low-P pasture soil for 8 weeks with and without the single and combined addition of P (33 mg kg) and nitrogen (200 mg kg). Phosphorus addition increased plant biomass and total P content across plant species, as well as microbial biomass P in white clover and ryegrass. Alkaline phosphatase activity was higher for blue lupin. Legumes showed higher concentrations of organic anions compared to grasses. After P addition, the concentrations of organic anions increased by 11-,10-, 5-, and 2-fold in the rhizospheres of blue lupin, white clover, wheat, and ryegrass, respectively. Despite the differences in their chemical availability (as assessed by P fractionation), moderately labile inorganic P and stable organic P were the most depleted fractions by the four plant species. Inorganic P fractions were depleted similarly between the four plant species, while blue lupin exhibited a strong depletion of stable organic P. Our findings suggest that organic anions were not related to the acquisition of inorganic P for legumes and grasses. At the same time, alkaline phosphatase activity was associated with the mobilization of stable organic P for blue lupin.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570192 | PMC |
http://dx.doi.org/10.3390/plants9091185 | DOI Listing |
J Am Coll Cardiol
December 2024
British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:
Background: Obesity is associated with excessive adipocyte-derived aldosterone secretion, independent of the classical renin-angiotensin-aldosterone cascade, and mineralocorticoid receptor antagonists may be more effective in patients with heart failure (HF) and obesity.
Objectives: This study sought to examine the effects of the nonsteroidal mineralocorticoid receptor antagonist finerenone compared with placebo, according to body mass index (BMI) in FINEARTS-HF (FINerenone trial to investigate Efficacy and sAfety superioR to placebo in paTientS with Heart Failure).
Methods: A total of 6,001 patients with HF with NYHA functional class II, III, and IV, a left ventricular ejection fraction of ≥40%, evidence of structural heart disease, and elevated natriuretic peptide levels were randomized to finerenone or placebo.
J Card Fail
November 2024
BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. Electronic address:
JAMA Cardiol
November 2024
British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
JAMA Cardiol
November 2024
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
J Am Coll Cardiol
September 2024
British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!